Want to see CHE full AI Analyst Report?
CHE Stock Chart & Stats
$384.61
$3.45(0.65%)
At close: 4:00 PM EST
$384.61
$3.45(0.65%)
Day’s Range― - ―
52-Week Range$365.21 - $511.85
Previous CloseN/A
Volume12.19K
Average Volume (3M)193.51K
Market Cap
$6.77B
Enterprise Value$5.40K
Total Cash (Recent Filing)$16.86M
Total Debt (Recent Filing)$236.93M
Price to Earnings (P/E)27.7
Beta0.24
Next Earnings
Jul 28, 2026EPS Estimate
5.6Next Dividend Ex-DateN/A
Dividend Yield0.47%
Share Statistics
EPS (TTM)18.39
Shares Outstanding13,274,104
10 Day Avg. Volume147,980
30 Day Avg. Volume193,515
Financial Highlights & Ratios
PEG Ratio-2.78
Price to Book (P/B)6.29
Price to Sales (P/S)2.43
P/FCF Ratio18.93
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$473.00Price Target Upside22.98% Upside
Rating ConsensusHold
Number of Analyst Covering2
EPS Forecast (FY)24.34
Revenue Forecast (FY)$2.69B
Bulls Say, Bears Say
Bulls Say
Strong Free Cash FlowConsistent high operating cash flow and FCF (TTM) provide durable internal financing for capex, buybacks, debt service and M&A. Strong cash conversion reduces reliance on external funding and supports capital allocation through business cycles, bolstering long‑term resilience.
Conservative LeverageLow debt relative to equity affords financial flexibility for acquisitions, weathering reimbursement or demand shocks, and maintains low default risk. High ROE indicates efficient capital deployment, supporting sustainable shareholder returns even amid episodic margin pressure.
VITAS-led Growth And Upgraded GuidanceVITAS’ rising admissions, higher revenue/day and upwardly revised company guidance reflect durable demand for hospice services and stronger reimbursement dynamics. This segment’s scale and steady payor relationships underpin predictable revenue and margin expansion over the next several quarters.
Bears Say
Roto‑Rooter Margin PressureSustained margin compression at Roto‑Rooter from higher paid marketing, weather disruptions and weaker branch revenues can erode consolidated profitability. Given the segment’s size, protracted pressure would structurally reduce cash flow contribution and constrain corporate margin recovery.
Water Restoration Pricing WeaknessMaterial declines in water restoration pricing and job revenue hurt unit economics and reduce margin leverage from centralization. If lower pricing and mix persist, expected benefits from acquisitions and billing changes may be offset, limiting durable margin improvement at Roto‑Rooter.
Say‑on‑pay RejectionA shareholder rejection of executive compensation signals governance and alignment concerns that can invite investor scrutiny, force board changes to pay structures, and increase oversight. Governance friction can slow strategy execution and raise the risk of activist engagement.
Chemed News
CHE FAQ
What was Chemed’s price range in the past 12 months?
Chemed lowest stock price was $365.20 and its highest was $511.85 in the past 12 months.
What is Chemed’s market cap?
Chemed’s market cap is $6.77B.
When is Chemed’s upcoming earnings report date?
Chemed’s upcoming earnings report date is Jul 28, 2026 which is in 8 days.
How were Chemed’s earnings last quarter?
Chemed released its earnings results on Apr 23, 2026. The company reported $5.65 earnings per share for the quarter, beating the consensus estimate of $5.302 by $0.348.
Is Chemed overvalued?
According to Wall Street analysts Chemed’s price is currently Undervalued.
Does Chemed pay dividends?
Chemed pays a Quarterly dividend of $0.6 which represents an annual dividend yield of 0.47%. See more information on Chemed dividends here
What is Chemed’s EPS estimate?
Chemed’s EPS estimate is 5.6.
How many shares outstanding does Chemed have?
Chemed has 13,274,104 shares outstanding.
What happened to Chemed’s price movement after its last earnings report?
Chemed reported an EPS of $5.65 in its last earnings report, beating expectations of $5.302. Following the earnings report the stock price went up 9.959%.
Which hedge fund is a major shareholder of Chemed?
Currently, no hedge funds are holding shares in CHE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Chemed Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$473.00 (22.98% Upside)
$473.00 (22.98% Upside)
Hedge Fund Trend
Increased
By 14.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 3.9%
Last 30 Days ▼ 3.9%
Technicals
SMA
Positive
20 days / 200 days
Momentum
12.09%
12-Months-Change
Fundamentals
Return on Equity
0.47%
Trailing 12-Months
Asset Growth
-11.05%
Trailing 12-Months
Company Description
Chemed
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
CHE Stock 12 Month Forecast
Average Price Target
$473.00
▲(22.98% Upside)
Technical Analysis
Ownership Overview
1.25% Insiders
30.78% Mutual Funds
2.60% Other Institutional Investors
36.13% Public Companies and
Individual Investors